MeSH Browser

MeSH Heading: Barth Syndrome
Tree Number(s): C14.240.400.172; C14.280.400.172; C16.131.077.121; C16.131.240.400.172; C16.320.322.068; C16.320.565.398.224; C18.452.584.563.224; C18.452.648.398.224
Unique ID: D056889
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D056889
Scope Note: Rare congenital X-linked disorder of lipid metabolism. Barth syndrome is transmitted in an X-linked recessive pattern. The syndrome is characterized by muscular weakness, growth retardation, DILATED CARDIOMYOPATHY, variable NEUTROPENIA, 3-methylglutaconic aciduria (type II) and decreases in mitochondrial CARDIOLIPIN level. Other biochemical and morphological mitochondrial abnormalities also exist.
Entry Term(s): 3-Methylglutaconic Aciduria, Type II; 3-Methylglutaconicaciduria Type 2; 3-Methylglutaconicaciduria Type II; Cardioskeletal Myopathy with Neutropenia and Abnormal Mitochondria; MGA Type 2; MGA Type II
See Also: Isolated Noncompaction of the Ventricular Myocardium
Public MeSH Note: 2010
History Note: 2010
Date Established: 2010/01/01
Date of Entry: 2009/07/06
Revision Date: 2021/06/30

Allowable Qualifiers: blood (BL)

cerebrospinal fluid (CF)

chemically induced (CI)

classification (CL)

complications (CO)

diagnosis (DI)

diagnostic imaging (DG)

diet therapy (DH)

drug therapy (DT)

economics (EC)

embryology (EM)

enzymology (EN)

epidemiology (EP)

ethnology (EH)

etiology (ET)

genetics (GE)

history (HI)

immunology (IM)

metabolism (ME)

microbiology (MI)

mortality (MO)

nursing (NU)

parasitology (PS)

pathology (PA)

physiopathology (PP)

prevention & control (PC)

psychology (PX)

radiotherapy (RT)

rehabilitation (RH)

surgery (SU)

therapy (TH)

urine (UR)

veterinary (VE)

virology (VI)

Concept UI: M0529363
Scope Note: Rare congenital X-linked disorder of lipid metabolism. Barth syndrome is transmitted in an X-linked recessive pattern. The syndrome is characterized by muscular weakness, growth retardation, DILATED CARDIOMYOPATHY, variable NEUTROPENIA, 3-methylglutaconic aciduria (type II) and decreases in mitochondrial CARDIOLIPIN level. Other biochemical and morphological mitochondrial abnormalities also exist.
Terms: Barth Syndrome Preferred Term
Term UI T734862
Date02/10/2009
LexicalTag EPO
ThesaurusID; 3-Methylglutaconic Aciduria, Type II
Term UI T822999
Date06/06/2012
LexicalTag NON
ThesaurusID OMIM (2013); MGA Type II
Term UI T824084
Date06/19/2012
LexicalTag ABX
ThesaurusID; 3-Methylglutaconicaciduria Type II
Term UI T823001
Date06/06/2012
LexicalTag NON
ThesaurusID; Cardioskeletal Myopathy with Neutropenia and Abnormal Mitochondria
Term UI T823002
Date06/06/2012
LexicalTag NON
ThesaurusID OMIM (2013); MGA Type 2
Term UI T751310
Date05/15/2009
LexicalTag ABX
ThesaurusID; 3-Methylglutaconicaciduria Type 2
Term UI T823000
Date06/06/2012
LexicalTag NON
ThesaurusID

Barth Syndrome MeSH Descriptor Data 2024